Ingredion Inc (INGR) is not a strong buy for a beginner, long-term investor at this moment. While the company has shown positive net income and EPS growth in the latest quarter, the technical indicators are bearish, insider selling is significant, and the CEO's recent share sale raises concerns about future performance. Additionally, the options data and analyst ratings do not indicate strong bullish sentiment. Given the user's preference for long-term investment and the current market conditions, it is better to hold off on investing in this stock for now.
The technical indicators for INGR are bearish. The MACD is negative and expanding downward, the RSI is neutral but leaning towards oversold territory, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 113.297 and resistance at 117.986.

Hedge funds have significantly increased their buying activity, up 137.50% over the last quarter. The company's net income and EPS have shown strong YoY growth in the latest quarter.
Insiders, including the CEO, have been selling shares significantly, with insider selling increasing by over 9 million percent in the last month. The CEO's sale of 23.2% of his holdings has raised concerns about the company's future performance. The company's Q4 revenue and gross margin have declined YoY, and the Texture & Healthful Solutions segment has shown weaker profits.
In Q4 2025, Ingredion's revenue dropped by 2.39% YoY to $1.757 billion. However, net income increased by 73.68% YoY to $165 million, and EPS rose by 79.72% YoY to 2.57. Gross margin declined slightly by 1.88% YoY to 24.47%.
Analysts have mixed views on INGR. UBS raised the price target to $124 but maintained a Neutral rating. BMO Capital lowered the price target to $120 and maintained a Market Perform rating, citing weaker profits in certain segments. Barclays raised the price target to $128 but highlighted headwinds from a facility outage.